Significant suppressive effect of low-dose temocapril, an ACE inhibitor with biliary excretion, on FGS lesions in hypertensive rats

Nephron

Volumn 86, Issue 4, 2000, Pages 491-498

  Suyama, Katsuo ^a   Muso, Eri ^a   Yashiro, Masatomo ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic FGS; Hypertension; PAN nephrosis; Renin angiotensin system; Temocapril

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PUROMYCIN AMINONUCLEOSIDE; TEMOCAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EXCRETION; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION; HYPERTENSION; MACROPHAGE; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; BILE; BLOOD PRESSURE; BLOTTING, NORTHERN; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; ORGAN SIZE; PROTAMINES; PROTO-ONCOGENE PROTEINS C-MYC; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, INBRED SHR; RNA, MESSENGER; THIAZEPINES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034532209     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045839     Document Type: Article

References (38)

1. Focal glomerulosclerosis: Natural history and treatment. A report of 70 cases
2. Focal segmental glomerulosclerosis
3. Focal segmental glomerulosclerosis with rapid decline in renal function ('malignant FSGS')
4. Low protein diet blunts the rise in glomerular gene expression in focal glomerulosclerosis
5. The renin-angiotensin system and vascular hypertrophy
6. The renin-angiotensin system: Revised concepts and implications for renal function
7. Internephron heterogeneity of growth factors and sclerosis
8. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
9. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury
10. Glomerular tumor necrosis factor and interleukin-1 during acute aminonucleoside nephrosis
11. Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells
12. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
13. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition
14. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms
15. The enhancement of aminonucleoside nephrosis by the co-administration of protamine
16. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage sub-populations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3
17. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
18. Progression of focal glomerulosclerosis in the spontaneously hypertensive rats
19. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome
20. LPS-induced MCP-1, IL-1β, and TNF-α mRNA expression in isolated erythrocyte-perfused rat kidney
21. In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis
22. Extra-cellular matrix component mRNA expression in glomeruli in experimental focal glomerulosclerosis
23. Enhanced production of glomerular extracellular matrix in a new mouse strain established by selective mating of high serum IgA ddY (HIGA) mice
24. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys
25. Expression of transforming growth factor-β isoforms in human glomerular diseases
26. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF-A-chain mediates the increase in cell size
27. The role of angiotensin II in vascular smooth muscle cell growth
28. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells
29. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury
30. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR
31. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy
32. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect
33. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation
34. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis
35. Angiotensin-converting enzyme inhibitors: Perhydro-1,4-thiazepin-5-one derivatives
36. Temocapril (CS-622), a novel angiotensin converting enzyme inhibitor
37. Single dose pharmacokinetics of temocapril (CS-622), a novel angiotensin converting enzyme inhibitor, in partially nephrectomised rats
38. Kininases